EDWARDS LIFESCIENCES CORP (EWL.DE) Stock Fundamental Analysis
FRA:EWL - Deutsche Boerse Ag - US28176E1082 - Common Stock - Currency: EUR
Taking everything into account, EWL scores 6 out of 10 in our fundamental rating. EWL was compared to 54 industry peers in the Health Care Equipment & Supplies industry. EWL has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. EWL is valied quite expensively at the moment, while it does show a decent growth rate. With these ratings, EWL could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
In the past year EWL was profitable.
EWL had a positive operating cash flow in the past year.
Each year in the past 5 years EWL has been profitable.
In the past 5 years EWL always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 31.98%, EWL belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of 41.75%, EWL belongs to the top of the industry, outperforming 98.15% of the companies in the same industry.
With an excellent Return On Invested Capital value of 9.05%, EWL belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
EWL had an Average Return On Invested Capital over the past 3 years of 12.44%. This is above the industry average of 7.93%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 31.98% | ||
| ROE | 41.75% | ||
| ROIC | 9.05% |
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
1.3 Margins
EWL has a better Profit Margin (76.28%) than 100.00% of its industry peers.
In the last couple of years the Profit Margin of EWL has grown nicely.
EWL has a better Operating Margin (27.13%) than 98.15% of its industry peers.
EWL's Operating Margin has been stable in the last couple of years.
With an excellent Gross Margin value of 79.23%, EWL belongs to the best of the industry, outperforming 85.19% of the companies in the same industry.
In the last couple of years the Gross Margin of EWL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.13% | ||
| PM (TTM) | 76.28% | ||
| GM | 79.23% |
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
2. Health
2.1 Basic Checks
EWL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for EWL has been reduced compared to 1 year ago.
EWL has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, EWL has an improved debt to assets ratio.
2.2 Solvency
EWL has an Altman-Z score of 11.34. This indicates that EWL is financially healthy and has little risk of bankruptcy at the moment.
EWL has a Altman-Z score of 11.34. This is amongst the best in the industry. EWL outperforms 98.15% of its industry peers.
The Debt to FCF ratio of EWL is 2.30, which is a good value as it means it would take EWL, 2.30 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of EWL (2.30) is better than 83.33% of its industry peers.
A Debt/Equity ratio of 0.06 indicates that EWL is not too dependend on debt financing.
EWL's Debt to Equity ratio of 0.06 is amongst the best of the industry. EWL outperforms 92.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 2.3 | ||
| Altman-Z | 11.34 |
ROIC/WACC1.03
WACC8.8%
2.3 Liquidity
EWL has a Current Ratio of 4.18. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of EWL (4.18) is better than 88.89% of its industry peers.
EWL has a Quick Ratio of 3.45. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
EWL has a Quick ratio of 3.45. This is amongst the best in the industry. EWL outperforms 88.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.18 | ||
| Quick Ratio | 3.45 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 1.96% over the past year.
EWL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.13% yearly.
Looking at the last year, EWL shows a decrease in Revenue. The Revenue has decreased by -6.00% in the last year.
EWL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.58% yearly.
EPS 1Y (TTM)1.96%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%-3.03%
Revenue 1Y (TTM)-6%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%-11.61%
3.2 Future
The Earnings Per Share is expected to grow by 9.41% on average over the next years. This is quite good.
Based on estimates for the next years, EWL will show a quite strong growth in Revenue. The Revenue will grow by 8.22% on average per year.
EPS Next Y-3.21%
EPS Next 2Y4.08%
EPS Next 3Y6.77%
EPS Next 5Y9.41%
Revenue Next Year0.76%
Revenue Next 2Y5.11%
Revenue Next 3Y6.88%
Revenue Next 5Y8.22%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 28.93, which means the current valuation is very expensive for EWL.
Based on the Price/Earnings ratio, EWL is valued a bit cheaper than the industry average as 72.22% of the companies are valued more expensively.
EWL is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.22, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 26.55, which means the current valuation is very expensive for EWL.
EWL's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 20.86. EWL is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.93 | ||
| Fwd PE | 26.55 |
4.2 Price Multiples
EWL's Enterprise Value to EBITDA is on the same level as the industry average.
EWL's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 170.46 | ||
| EV/EBITDA | 24.39 |
4.3 Compensation for Growth
The excellent profitability rating of EWL may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)4.06
EPS Next 2Y4.08%
EPS Next 3Y6.77%
5. Dividend
5.1 Amount
No dividends for EWL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:EWL (4/29/2025, 7:00:00 PM)
66.26
+0.04 (+0.06%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners88.15%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap38.95B
Analysts73.66
Price Target70.33 (6.14%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.48%
Min EPS beat(2)1.57%
Max EPS beat(2)3.4%
EPS beat(4)2
Avg EPS beat(4)0.64%
Min EPS beat(4)-2.08%
Max EPS beat(4)3.4%
EPS beat(8)2
Avg EPS beat(8)-0.63%
EPS beat(12)4
Avg EPS beat(12)-0.95%
EPS beat(16)6
Avg EPS beat(16)-0.03%
Revenue beat(2)0
Avg Revenue beat(2)-7.33%
Min Revenue beat(2)-13.79%
Max Revenue beat(2)-0.87%
Revenue beat(4)0
Avg Revenue beat(4)-4.96%
Min Revenue beat(4)-13.79%
Max Revenue beat(4)-0.87%
Revenue beat(8)1
Avg Revenue beat(8)-2.81%
Revenue beat(12)1
Avg Revenue beat(12)-2.8%
Revenue beat(16)3
Avg Revenue beat(16)-2.25%
PT rev (1m)-9.23%
PT rev (3m)-8.78%
EPS NQ rev (1m)-0.23%
EPS NQ rev (3m)2.05%
EPS NY rev (1m)0.01%
EPS NY rev (3m)0.89%
Revenue NQ rev (1m)-0.07%
Revenue NQ rev (3m)-2.17%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-0.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.93 | ||
| Fwd PE | 26.55 | ||
| P/S | 8.09 | ||
| P/FCF | 170.46 | ||
| P/OCF | 81.69 | ||
| P/B | 4.43 | ||
| P/tB | 6.29 | ||
| EV/EBITDA | 24.39 |
EPS(TTM)2.29
EY3.46%
EPS(NY)2.5
Fwd EY3.77%
FCF(TTM)0.39
FCFY0.59%
OCF(TTM)0.81
OCFY1.22%
SpS8.19
BVpS14.95
TBVpS10.54
PEG (NY)N/A
PEG (5Y)4.06
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 31.98% | ||
| ROE | 41.75% | ||
| ROCE | 12.86% | ||
| ROIC | 9.05% | ||
| ROICexc | 13.8% | ||
| ROICexgc | 22.62% | ||
| OM | 27.13% | ||
| PM (TTM) | 76.28% | ||
| GM | 79.23% | ||
| FCFM | 4.75% |
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
ROICexc(3y)16.13%
ROICexc(5y)17.4%
ROICexgc(3y)22.87%
ROICexgc(5y)24.4%
ROCE(3y)17.66%
ROCE(5y)19.29%
ROICexcg growth 3Y-5.47%
ROICexcg growth 5Y-8.01%
ROICexc growth 3Y-11.82%
ROICexc growth 5Y-8.6%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
F-Score7
Asset Turnover0.42
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 2.3 | ||
| Debt/EBITDA | 0.36 | ||
| Cap/Depr | 181.96% | ||
| Cap/Sales | 5.16% | ||
| Interest Coverage | 75.76 | ||
| Cash Conversion | 33.07% | ||
| Profit Quality | 6.23% | ||
| Current Ratio | 4.18 | ||
| Quick Ratio | 3.45 | ||
| Altman-Z | 11.34 |
F-Score7
WACC8.8%
ROIC/WACC1.03
Cap/Depr(3y)185.14%
Cap/Depr(5y)236.01%
Cap/Sales(3y)5.48%
Cap/Sales(5y)6.41%
Profit Quality(3y)37.92%
Profit Quality(5y)57.13%
High Growth Momentum
Growth
EPS 1Y (TTM)1.96%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%-3.03%
EPS Next Y-3.21%
EPS Next 2Y4.08%
EPS Next 3Y6.77%
EPS Next 5Y9.41%
Revenue 1Y (TTM)-6%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%-11.61%
Revenue Next Year0.76%
Revenue Next 2Y5.11%
Revenue Next 3Y6.88%
Revenue Next 5Y8.22%
EBIT growth 1Y-15.39%
EBIT growth 3Y-4.72%
EBIT growth 5Y3.49%
EBIT Next Year8%
EBIT Next 3Y10.92%
EBIT Next 5Y10.65%
FCF growth 1Y-58.71%
FCF growth 3Y-42.99%
FCF growth 5Y-22.01%
OCF growth 1Y-39.46%
OCF growth 3Y-32.1%
OCF growth 5Y-14.39%